Reverse vaccinology, a genome-based approach to vaccine development

Vaccine

Volumn 19, Issue 17-19, 2001, Pages 2688-2691

  Rappuoli, Rino ^a  

^a CHIRON VACCINES   (Italy)

Author keywords

Genomics; Meningococcus B vaccine; Reverse vaccinology

Indexed keywords

MENINGOCOCCUS VACCINE; VIRUS VACCINE;

CONFERENCE PAPER; DRUG SCREENING; MOLECULAR CLONING; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE; VACCINE PRODUCTION; VIRUS CULTURE; VIRUS GENOME; VIRUS IMMUNITY;

DRUG DESIGN; GENOME; HUMANS; NEISSERIA MENINGITIDIS; VACCINES; VIRAL VACCINES;

EID: 0035925596     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00554-5     Document Type: Conference Paper

References (8)

1. Identification of vaccine targets
2. Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques
3. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat pro vaccine
4. Vaccination with Rev and Tat against AIDS
5. New and improved vaccines against meningococcal disease
6. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58
7. Whole genome sequencing to identify vaccine candidates against serogroup B meningococcus